Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells.

De Trez C, Schneider K, Potter K, Droin N, Fulton J, Norris PS, Ha SW, Fu YX, Murphy T, Murphy KM, Pfeffer K, Benedict CA, Ware CF.

J Immunol. 2008 Jan 1;180(1):238-48.

2.

The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis.

De Trez C, Ware CF.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):277-84. doi: 10.1016/j.cytogfr.2008.04.013. Epub 2008 Jun 3. Review.

3.

The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.

Steinberg MW, Cheung TC, Ware CF.

Immunol Rev. 2011 Nov;244(1):169-87. doi: 10.1111/j.1600-065X.2011.01064.x. Review.

4.

Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Ware CF.

Immunol Rev. 2008 Jun;223:186-201. doi: 10.1111/j.1600-065X.2008.00629.x. Review.

5.
6.

The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.

Cai G, Freeman GJ.

Immunol Rev. 2009 May;229(1):244-58. doi: 10.1111/j.1600-065X.2009.00783.x. Review.

PMID:
19426226
7.

BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection.

Steinberg MW, Huang Y, Wang-Zhu Y, Ware CF, Cheroutre H, Kronenberg M.

PLoS One. 2013 Oct 30;8(10):e77992. doi: 10.1371/journal.pone.0077992. eCollection 2013.

8.

CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA.

Flynn R, Hutchinson T, Murphy KM, Ware CF, Croft M, Salek-Ardakani S.

PLoS One. 2013 Oct 29;8(10):e77991. doi: 10.1371/journal.pone.0077991. eCollection 2013.

9.

Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.

Kojima R, Kajikawa M, Shiroishi M, Kuroki K, Maenaka K.

J Mol Biol. 2011 Nov 4;413(4):762-72. doi: 10.1016/j.jmb.2011.09.018. Epub 2011 Sep 19.

PMID:
21959263
10.

B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.

Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, Scheu S, Pfeffer K, Ware CF, Murphy TL, Murphy KM.

Nat Immunol. 2005 Jan;6(1):90-8. Epub 2004 Nov 28.

11.

CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.

Šedý JR, Bjordahl RL, Bekiaris V, Macauley MG, Ware BC, Norris PS, Lurain NS, Benedict CA, Ware CF.

J Immunol. 2013 Jul 15;191(2):828-36. doi: 10.4049/jimmunol.1300894. Epub 2013 Jun 12.

12.

Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo.

Abe K, Yarovinsky FO, Murakami T, Shakhov AN, Tumanov AV, Ito D, Drutskaya LN, Pfeffer K, Kuprash DV, Komschlies KL, Nedospasov SA.

Blood. 2003 Feb 15;101(4):1477-83.

13.

T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.

Cheung TC, Oborne LM, Steinberg MW, Macauley MG, Fukuyama S, Sanjo H, D'Souza C, Norris PS, Pfeffer K, Murphy KM, Kronenberg M, Spear PG, Ware CF.

J Immunol. 2009 Dec 1;183(11):7286-96. doi: 10.4049/jimmunol.0902490. Epub 2009 Nov 13.

14.

Intestinal cryptopatch formation in mice requires lymphotoxin alpha and the lymphotoxin beta receptor.

Taylor RT, Lügering A, Newell KA, Williams IR.

J Immunol. 2004 Dec 15;173(12):7183-9.

15.

Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.

Cheung TC.

Recent Pat DNA Gene Seq. 2009;3(3):177-82. Review.

PMID:
19702559
16.

Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM.

Murphy TL, Murphy KM.

Annu Rev Immunol. 2010;28:389-411. doi: 10.1146/annurev-immunol-030409-101202. Review.

PMID:
20307212
17.

Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.

del Rio ML, Jones ND, Buhler L, Norris P, Shintani Y, Ware CF, Rodriguez-Barbosa JI.

J Immunol. 2012 May 15;188(10):4885-96. doi: 10.4049/jimmunol.1103698. Epub 2012 Apr 6.

18.

Lymphotoxin-β receptor activation by lymphotoxin-α(1)β(2) and LIGHT promotes tumor growth in an NFκB-dependent manner.

Daller B, Müsch W, Röhrl J, Tumanov AV, Nedospasov SA, Männel DN, Schneider-Brachert W, Hehlgans T.

Int J Cancer. 2011 Mar 15;128(6):1363-70. doi: 10.1002/ijc.25456.

19.

A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.

Gonzalez LC, Loyet KM, Calemine-Fenaux J, Chauhan V, Wranik B, Ouyang W, Eaton DL.

Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1116-21. Epub 2005 Jan 12.

20.

The expression and anatomical distribution of BTLA and its ligand HVEM in rheumatoid synovium.

Shang Y, Guo G, Cui Q, Li J, Ruan Z, Chen Y.

Inflammation. 2012 Jun;35(3):1102-12. doi: 10.1007/s10753-011-9417-2.

PMID:
22179929

Supplemental Content

Support Center